Mobile

A multicenter, multi-national, randomized, double-blind, placebo-controlled, study to assess the efficacy and safety of ciclesonide metered-dose inhaler at 80 μg BID or 40 μg BID for 12 weeks in patie...

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-004740-22

A multicenter, multi-national, randomized, double-blind, placebo-controlled, study to assess the efficacy and safety of ciclesonide metered-dose inhaler at 80 μg BID or 40 μg BID for 12 weeks in patients aged 4 to <12 years with persistent asthma

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To demonstrate the efficacy of ciclesonide, compared to placebo, at 80 μg BID or 40 μg BID for 12 weeks in patients aged 4 to <12 years with persistent asthma.

Critère d'inclusion

  • patients aged 4 to <12 years with persistent asthma

Liens